These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 21111509

  • 1. Thymidylate synthase and dihydropyrimidine dehydrogenase expression levels are associated with response to S-1 plus carboplatin in advanced non-small cell lung cancer.
    Takeda M, Okamoto I, Hirabayashi N, Kitano M, Nakagawa K.
    Lung Cancer; 2011 Jul; 73(1):103-9. PubMed ID: 21111509
    [Abstract] [Full Text] [Related]

  • 2. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (tegafur+uracil) in patients with non-small cell lung cancer.
    Miyoshi T, Kondo K, Toba H, Yoshida M, Fujino H, Kenzaki K, Sakiyama S, Takehisa M, Tangoku A.
    Anticancer Res; 2007 Jul; 27(4C):2641-8. PubMed ID: 17695427
    [Abstract] [Full Text] [Related]

  • 3. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Harada K, Ferdous T, Itashiki Y, Takii M, Mano T, Mori Y, Ueyama Y.
    Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
    [Abstract] [Full Text] [Related]

  • 4. Quantitative double-fluorescence immunohistochemistry (qDFIHC), a novel technology to assess protein expression: a pilot study analyzing 5-FU sensitive markers thymidylate synthase, dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferases in gastric cancer tissue specimens.
    Kai K, Kitajima Y, Hiraki M, Satoh S, Tanaka M, Nakafusa Y, Tokunaga O, Miyazaki K.
    Cancer Lett; 2007 Dec 08; 258(1):45-54. PubMed ID: 17892912
    [Abstract] [Full Text] [Related]

  • 5. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA levels in tumor tissues and the efficacy of 5-fluorouracil in patients with non-small-cell lung cancer.
    Shintani Y, Ohta M, Hirabayashi H, Tanaka H, Iuchi K, Nakagawa K, Maeda H, Kido T, Miyoshi S, Matsuda H.
    Lung Cancer; 2004 Aug 08; 45(2):189-96. PubMed ID: 15246190
    [Abstract] [Full Text] [Related]

  • 6. [Results of prophylactic hepatic arterial chemotherapy for liver metastases of Dukes C colorectal cancer--correlation with tumoral expression of dihydropyrimidine dehydrogenase, thymidylate synthase, p53, or orotate phosphoribosyl transferase].
    Ishida H, Yamada H, Shirakawa K, Nakada H, Ohsawa T, Takeuchi I, Okada N, Yokoyama M, Inokuma S, Suzuki T, Odaka A, Hoshino T, Murata N, Hashimoto D, Itoyama S, Mori T, Matsumoto Y, Miura T.
    Gan To Kagaku Ryoho; 2003 Oct 08; 30(11):1621-6. PubMed ID: 14619479
    [Abstract] [Full Text] [Related]

  • 7. Intratumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer patients treated with 5-FU-based chemotherapy.
    Huang CL, Yokomise H, Kobayashi S, Fukushima M, Hitomi S, Wada H.
    Int J Oncol; 2000 Jul 08; 17(1):47-54. PubMed ID: 10853017
    [Abstract] [Full Text] [Related]

  • 8. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Itashiki Y, Harada K, Ferdous T, Yoshida H.
    Anticancer Res; 2007 Jul 08; 27(4B):2365-75. PubMed ID: 17695527
    [Abstract] [Full Text] [Related]

  • 9. Thymidylate synthase expression in oral squamous cell carcinoma predicts response to S-1.
    Harada K, Kawashima Y, Yoshida H, Sato M.
    Oncol Rep; 2006 Jun 08; 15(6):1417-23. PubMed ID: 16685374
    [Abstract] [Full Text] [Related]

  • 10. Thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer: relationship between mRNA expression and activity.
    Miyoshi T, Kondo K, Fujino H, Takahashi Y, Sawada N, Sakiyama S, Tsuyuguchi M, Kimura S, Sumitomo M, Monden Y.
    Anticancer Res; 2005 Jun 08; 25(2A):923-30. PubMed ID: 15868929
    [Abstract] [Full Text] [Related]

  • 11. Effects of UFT on thymidylate synthase and dihydropyrimidine dehydrogenase activities in lung cancer.
    Miyamoto H, Morio A, Izumi H, Yamazaki A, Wang Z, Futagawa T, Sonobe S.
    Anticancer Res; 2003 Jun 08; 23(5b):4153-6. PubMed ID: 14666617
    [Abstract] [Full Text] [Related]

  • 12. [Expression of mRNA levels of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase of colorectal cancer--relationships among mRNA levels in association with response to 5-FU based treatment].
    Ishida H, Shirakawa K, Ohsawa T, Sobajima J, Hayashi Y, Nakada H, Yokoyama M, Hashimoto D.
    Gan To Kagaku Ryoho; 2005 Nov 08; 32(12):1929-34. PubMed ID: 16282729
    [Abstract] [Full Text] [Related]

  • 13. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M, Quirino M, Schinzari G, Zannoni G, Corsi DC, Vecchio FM, Cassano A, La Torre G, Barone C.
    Oncology; 2006 Nov 08; 70(5):366-77. PubMed ID: 17179731
    [Abstract] [Full Text] [Related]

  • 14. Paclitaxel plus carboplatin in the treatment of patients with advanced lung cancer: a Vanderbilt University Cancer Center phase II trial (LUN-46).
    Johnson DH, Paul DM, Hande KR, DeVore R.
    Semin Oncol; 1996 Dec 08; 23(6 Suppl 16):42-6. PubMed ID: 9007120
    [Abstract] [Full Text] [Related]

  • 15. In vitro sensitivity to platinum-derived drugs is associated with expression of thymidylate synthase and dihydropyrimidine dehydrogenase in human lung cancer.
    Takizawa M, Kawakami K, Obata T, Matsumoto I, Ohta Y, Oda M, Sasaki T, Watanabe G.
    Oncol Rep; 2006 Jun 08; 15(6):1533-9. PubMed ID: 16685392
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and toxicity of S-1 plus cisplatin combination neoadjuvant chemotherapy in patients with oral cancer.
    Kawasaki G, Yoshitomi I, Yanamoto S, Yamada S, Mizuno A.
    Gan To Kagaku Ryoho; 2011 Jun 08; 38(6):951-7. PubMed ID: 21677485
    [Abstract] [Full Text] [Related]

  • 17. Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
    Azuma K, Sasada T, Kawahara A, Takamori S, Hattori S, Ikeda J, Itoh K, Yamada A, Kage M, Kuwano M, Aizawa H.
    Lung Cancer; 2009 Jun 08; 64(3):326-33. PubMed ID: 18977553
    [Abstract] [Full Text] [Related]

  • 18. Effects of combined administration of DPD-inhibitory oral fluoropyrimidine, S-1, plus paclitaxel on gene expressions of fluoropyrimidine metabolism-related enzymes in human gastric xenografts.
    Sakurai Y, Yoshida I, Kamoshida S, Inaba K, Isogaki J, Komori Y, Uyama I, Tsutsumi Y.
    Ann Surg Oncol; 2008 Aug 08; 15(8):2301-9. PubMed ID: 18506536
    [Abstract] [Full Text] [Related]

  • 19. Phase 2 study of S-1 plus carboplatin in patients with advanced non-small cell lung cancer.
    Kaira K, Sunaga N, Yanagitani N, Imai H, Utsugi M, Iwasaki Y, Shimizu K, Iijima H, Tsurumaki H, Tomizawa Y, Hisada T, Ishizuka T, Saito R, Mori M.
    Lung Cancer; 2010 May 08; 68(2):253-7. PubMed ID: 19631403
    [Abstract] [Full Text] [Related]

  • 20. Expression of thymidylate synthase, orotate phosphoribosyltransferase and dihydropyrimidine dehydrogenase in thymic epithelial tumors.
    Kaira K, Serizawa M, Koh Y, Miura S, Kaira R, Abe M, Nakagawa K, Ohde Y, Okumura T, Murakami H, Tsuya A, Nakamura Y, Naito T, Takahashi T, Kondo H, Nakajima T, Endo M, Yamamoto N.
    Lung Cancer; 2011 Dec 08; 74(3):419-25. PubMed ID: 21550686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.